North China Pharmaceutical (SHA:600812) agreed to receive financial services from Jizhong Energy Group Finance for three years, according to a Wednesday disclosure on the Shanghai bourse.
The financial services will include deposit, settlement, credit, intermediary, and cash pooling management services.
Under the deal, the Chinese pharmaceutical company's daily deposits will not exceed 1 billion yuan, while annual credit should be at least 1 billion yuan.
North China Pharmaceutical's shares slipped over 1% in recent trade.